The change in sentiment is not permanent, this company has so many things going and I see a series of good news about to hit the market, some -including the AD results - will help post-validate the acne trial, others - like the upcoming 1801 study - will make the market (and the scientific community) - take notice.
The rosacea trial is about to start too and with its known anti-inflammatory effects BOT' synthetic is an excellent candidate for a novel topical drug.
Phase 3 for BTX1503 will go ahead.
All IMO, DYOR, not financial advise, etc. etc
The change in sentiment is not permanent, this company has so...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $456.7M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.5¢ | 29.0¢ | $1.147M | 3.861M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 589472 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 39319 | 2 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
29.0¢ |
Change
0.000 ( 1.13 %) |
||||
| Open | High | Low | Volume | ||
| 29.5¢ | 30.5¢ | 29.0¢ | 2638633 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| BOT (ASX) Chart |